Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises

MarketNewsUpdates News Commentary

NEW YORK, Sept. 18, 2025 /CNW/ -- Cell therapy refers to a treatment that involves the use of living cells to treat diseases. The cell therapy market has been experiencing significant growth due to the rising awareness about the benefits of cell therapies. They help regenerate damaged tissues and organs. They have the potential to treat a range of conditions, such as cancer, autoimmune diseases, infectious diseases, urinary issues, spinal cord injuries, joint cartilage damage, immune system weakness, and neurological disorders. Cell therapies target only damaged tissues, reducing the chances of getting damage to other tissues. Numerous cell types are used as part of a therapy or treatment for various illnesses. The demand for cellular therapy is increasing rapidly, contributing to the growth of the market. Transplanting human cells to replace or repair damaged tissue and/or cells is known as cellular therapy (CT). Cell therapies enhance patient outcomes due to their fewer side effects. According to a report from BioSpace the global cell therapy market size was USD 5.88 billion in 2024 and is expected to reach around USD 44.39 billion by 2034, expanding at a compound annual growth rate (CAGR) of 22.69% between 2025 and 2034. The growth of the cell therapy market is driven by the increase in investments in research and development and advancements in biotechnology. Healthcare companies active in the markets this week include: Avant Technologies Inc. (OTC-BB:AVAI), Tempus AI, Inc. (NASDAQ:TEM), CRISPR Therapeutics (NASDAQ:CRSP), BioNTech SE (NASDAQ:BNTX), Bristol Myers Squibb Company (NYSE:BMY).